GRANULES Intraday Analysis...

GRANULES Share Price

Open 137.00 Change Price %
High 138.85 1 Day -1.15 -0.84
Low 133.05 1 Week -5.85 -4.13
Close 135.70 1 Month -4.55 -3.24
Volume 1930122 1 Year -3.85 -2.76
52 Week High 157.25
52 Week Low 91.45
GRANULES Important Levels
Resistance 2 141.08
Resistance 1 138.86
Pivot 135.87
Support 1 132.54
Support 2 130.32
NSE INDIA Most Active Stocks
JPASSOCIAT 18.75 14.33%
GMRINFRA 21.35 2.64%
RCOM 21.20 5.47%
IBREALEST 204.45 6.48%
FORTIS 172.50 -12.83%
SBIN 288.95 -1.88%
SUZLON 18.40 -1.60%
HDIL 85.85 -1.27%
DLF 192.05 -1.92%
ICICIBANK 291.85 0.78%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.15 50.00%
SPYL 0.30 20.00%
KARMAENG 46.95 19.92%
ARCOTECH 96.65 19.32%
CIGNITITEC 303.35 14.75%
JPASSOCIAT 18.75 14.33%
SHRIRAMEPC 26.65 11.51%
TI 12.15 9.95%
TI 12.15 9.95%
SAMTEL 0.60 9.09%
More..
NSE INDIA Top Losers Stocks
RASOYPR 0.10 -33.33%
REIAGROLTD 0.30 -14.29%
FORTIS 172.50 -12.83%
SPCENET 0.40 -11.11%
NICCO 0.40 -11.11%
IFBAGRO 431.85 -8.20%
CASTEXTECH 7.90 -7.60%
NEXTMEDIA 20.15 -6.93%
ANKITMETAL 1.35 -6.90%
ESL 4.15 -6.74%
More..

Granules India Limited (NSE: GRANULES)

GRANULES Technical Analysis 2
As on 23rd Jun 2017 GRANULES Share Price closed @ 135.70 and we RECOMMEND Buy for LONG-TERM with Stoploss of 127.11 & Strong Sell for SHORT-TERM with Stoploss of 141.98 we also expect STOCK to react on Following IMPORTANT LEVELS.
GRANULES Target for June
1st Target up-side 152.45
2nd Target up-side 162.19
3rd Target up-side 171.93
1st Target down-side 124.65
2nd Target down-side 114.91
3rd Target down-side 105.17
GRANULES Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 40.31 Sideways
MFI (14) MFI is 44.16 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is -79.46 Sideways
ADX (14) ADX is 14.17 Range Bound
PSAR Stoploss For Short Sell 145.95
10 Day Avg Volume Traded 55.91 % More then 10 Day Average Volume
GRANULES Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.granulesindia.com
GRANULES Address
GRANULES
My Home Hub
2nd Floor
Hyderabad, 500081
India
Phone: 91 40 6676 0000
Fax: 91 40 2311 5145
GRANULES Latest News
Granules India Ltd to de-list GDR in Luxembourg Stock Exchange   Equity Bulls   - 19th Mar 15
Granules India seeks delisting of GDRs   Hindu Business Line   - 17th Mar 15
US FDA inspects Granules India facility   Business Standard   - 16th Mar 15
Granules India Ltd Fixes Record Date for Stock Split   Equity Bulls   - 10th Mar 15
Granules India, Belgian firm Ajinomoto OmniChem open APIs facility   Business Standard   - 24th Feb 15
Granules India to raise Rs 250 cr via QIP: VVS Murthy   Economic Times   - 05th Feb 15
Granules India to raise Rs. 250 cr   Hindu Business Line   - 28th Jan 15
Granules India Limited   Moneycontrol.com   - 28th Jan 15
Granules India Ltd to consider quarterly results on Jan 28, 2015   Equity Bulls   - 01st Jan 15
Granules India looks at further expansion   Business Standard   - 28th Nov 13
Interactive Technical Analysis Chart Granules India Limited ( GRANULES NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Granules India Limited
GRANULES Business Profile
Granules India is in the Pharmaceuticals sector. Granules’ predecessor company, a partnership called Umbrella Laboratories, was established in 1984, and the company is based in Hyderabad, India. The Company manufactures Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) which are distributed in over 50 countries. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and semi-regulated markets. In 2008, Granules commenced operations at its finished dosage block at Gagillapur. The new block has enabled Granules to provide products throughout the pharmaceutical value chain to customers. The state-of-the-art facility has an annual capacity of 6 billion tablets per year and is scalable up to 12 billion tablets per year. The third piece of the business is the API division. Granules manufactures APIs for several drugs including Paracetamol, Ibuprofen, Metformin and Guaifenesin through 3 facilities. The current market capitalisation stands at Rs 333.94 crore.The company has reported a consolidated sales of Rs 266.05 crore and a Net Profit of Rs 15.11 crore for the quarter ended Sep 2013. The company management includes C Nageswara Rao - Chairman, C Krishna Prasad - Managing Director, L S Sarma - Director, A P Kurian - Director, C Parthasarathy - Director, Krishna Murthy Ella - Director, Arun Rao Akinepally - Director, Harsha Chigurupati - Executive Director, Uma Chigurupati - Executive Director, K B Sankara Rao - Additional Director. It is listed on the BSE with a BSE Code of 532482 and the NSE with an NSE Code of GRANULES. Its Registered office is at 2nd Floor, 3rd Block,,My Home Hub, Hyderabad,Andhra Pradesh - 500081.